Merit medical forecasts 2020 gaap earnings per share between $0.62 and $0.72

Merit medical reports earnings for fourth quarter and year ended december 31, 2019, gives fy 2020 guidance.q4 non-gaap earnings per share $0.40.q4 gaap loss per share $0.08.q4 revenue $257.9 million versus refinitiv ibes estimate of $252.3 million.q4 earnings per share estimate $0.34 -- refinitiv ibes data.sees 2020 net sales $1,044- $1,064 million.sees 2020 gaap earnings per share $0.62 - $0.72.sees 2020 non-gaap earnings per share $1.58 - $1.68.merit medical - too early to adequately forecast potential impact, or duration, of coronavirus outbreak on merit’s 2020 financial performance.merit medical - estimates a full quarter of continued coronavirus outbreak at current levels could impact net sales in $14 million - $19 million range.merit medical - estimates a full quarter of continued coronavirus outbreak at current levels could impact non-gaap eps in $0.08 to $0.12 range.fy2020 earnings per share view $1.56, revenue view $1.05 billion -- refinitiv ibes data.
MMSI Ratings Summary
MMSI Quant Ranking